BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30043277)

  • 1. Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.
    Zhang Y; Zhang M; Jiang Y; Li X; He Y; Zeng P; Guo Z; Chang Y; Luo H; Liu Y; Hao C; Wang H; Zhang G; Zhang L
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2177-2186. PubMed ID: 30043277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China.
    Zhang M; Zhang Y; Zhang L; Tian Q
    Prog Mol Biol Transl Sci; 2019; 163():297-328. PubMed ID: 31030752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentinan combined with cisplatin for the treatment of non-small cell lung cancer.
    Zhao C; Yan H; Pang W; Wu T; Kong X; Li X; Liu H; Zhao L; Liang F; Jia Y
    Medicine (Baltimore); 2021 Mar; 100(12):e25220. PubMed ID: 33761711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer.
    Yin X; Ying J; Li L; Zhang H; Wang H
    Indian J Cancer; 2015 Nov; 52 Suppl 1():e29-31. PubMed ID: 26548936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines.
    Xiao Z; Wang C; Sun Y; Li N; Li J; Chen L; Yao X; Ding J; Ma H
    Medicine (Baltimore); 2016 Nov; 95(44):e5210. PubMed ID: 27858864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?: A meta-analysis of 16 randomized controlled trials following the PRISMA guidelines.
    Xiao Z; Liang R; Wang CQ; Xu S; Li N; He Y; Tang F; Chen L; Ma H
    Medicine (Baltimore); 2016 Aug; 95(35):e4517. PubMed ID: 27583861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentinan progress in inflammatory diseases and tumor diseases.
    Zhou G; Liu H; Yuan Y; Wang Q; Wang L; Wu J
    Eur J Med Res; 2024 Jan; 29(1):8. PubMed ID: 38172925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of lentinan for treating gastric cancer.
    Ina K; Kataoka T; Ando T
    Anticancer Agents Med Chem; 2013 Jun; 13(5):681-8. PubMed ID: 23092289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials.
    Xiao Z; Wang C; Tan Z; Hu S; Chen Y; Zhou M; Feng J; Liu S; Chen L; Ding J; Gong Q; Tang F; Liu H; Li X
    J Clin Pharm Ther; 2019 Feb; 44(1):23-38. PubMed ID: 30229971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
    Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
    J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials.
    Yang J; Zhu X; Yuan P; Liu J; Wang B; Wang G
    Support Care Cancer; 2020 Aug; 28(8):3571-3579. PubMed ID: 32266566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinobufotalin injection combined with chemotherapy for the treatment of advanced NSCLC in China: A PRISMA-compliant meta-analysis of 29 randomized controlled trials.
    Zhang F; Yin Y; Xu T
    Medicine (Baltimore); 2019 Aug; 98(35):e16969. PubMed ID: 31464940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.
    Oba K; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
    Anticancer Res; 2009 Jul; 29(7):2739-45. PubMed ID: 19596954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
    Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
    Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis.
    Liu ZL; Wang Q; Wang M; Wang B; Huang LN
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S437-S443. PubMed ID: 29970703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on the efficiency of lentinan for injection combining cisplatin on treating malignant pleural effusion based on systematic review and meta-analysis.
    Wang Y; Wang H; Chai K; Guo S; Gao Y; Li J; Qiao C; Yang S; Zhou J; Lin Y; Zhang X; Wu J
    Medicine (Baltimore); 2024 May; 103(21):e38032. PubMed ID: 38788041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
    Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
    Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.
    Xiao Z; Wang CQ; Feng JH; Zhou MH; Wang YZ; Li NN; Sun YP; Liu SY; Yao XS; Li CW; Ma B; Ding J; Chen L
    Cytotherapy; 2019 Feb; 21(2):125-147. PubMed ID: 30554868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ginseng and its ingredients as adjuvants to chemotherapy in non-small cell lung cancer.
    Zhu H; Liu H; Zhu JH; Wang SY; Zhou SS; Kong M; Mao Q; Long F; Fang ZJ; Li SL
    Food Funct; 2021 Mar; 12(5):2225-2241. PubMed ID: 33595586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gefitinib for advanced non-small cell lung cancer.
    Sim EH; Yang IA; Wood-Baker R; Bowman RV; Fong KM
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD006847. PubMed ID: 29336009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.